Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcomes in Newly Diagnosed Hypertensive Patients With EXTOR (Fixed-Dose Combination of Amlodipine/Valsartan) in Routine Pakistani Practice.

NCT06625346 is registered in ClinicalTrials.gov with The Searle Company Limited Pakistan as lead sponsor.

NCT NCT06625346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06625346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcomes in Newly Diagnosed Hypertensive Patients With EXTOR (Fixed-Dose Combination of Amlodipine/Valsartan) in Routine Pakistani Practice.
Lead sponsor
The Searle Company Limited Pakistan
Phase
Observational
Overall status
Recruiting
Start date
September 28, 2024
Completion date
September 15, 2025
Enrollment
420 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension